Abacavir, dolutegravir, and lamivudine and Eloctate
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Eloctate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Eloctate with Fc Fusion Protein (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Eloctate with Fc Fusion Protein recombinant
- Abacavir, dolutegravir, and lamivudine-Elotuzumab
- Abacavir, dolutegravir, and lamivudine-Elotuzumab Intravenous
- Abacavir, dolutegravir, and lamivudine-Eloxatin
- Abacavir, dolutegravir, and lamivudine-Elppa CoQ10 coenzyme Q-10
- Abacavir, dolutegravir, and lamivudine-Elspar
- Eloctate-Abacavir, Lamivudine and Zidovudine Tablets
- Eloctate-Abacavir, lamivudine, and zidovudine
- Eloctate-Abaloparatide
- Eloctate-Abaloparatide Subcutaneous
- Eloctate-Abatacept
- Eloctate-Abatacept Auto-Injectors